Forane Inhalant
NDC Package 10019-360-40

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Forane (isoflurane) inhalants is fORANE may be used for induction and maintenance of general anesthesia. This formulation utilizes a inhalant delivery system. Marketed by Baxter Healthcare Corporation, this product is identified by NDC 10019-360 and is authorized under FDA application NDA017624.

Identification & Billing

NDC Package Code
10019-360-40
Package Description
6 BOTTLE, GLASS in 1 PACKAGE / 100 mL in 1 BOTTLE, GLASS
Product Code
11-Digit Billing Format
10019036040
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Forane
Non-Proprietary Name
Isoflurane
Substance Name
Isoflurane
Dosage Form
Inhalant - A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler.
Administration Route
Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
Active Ingredient(s)
Usage Information
FORANE may be used for induction and maintenance of general anesthesia. Adequate data have not been developed to establish its application in obstetrical anesthesia.

Regulatory & Marketing

Labeler Name
Baxter Healthcare Corporation
Product Type
Human Prescription Drug
FDA Application #
NDA017624
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-18-1979
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (10019-360). Click a package code to view its specific billing and regulatory data.

6 BOTTLE, GLASS in 1 PACKAGE / 250 mL in 1 BOTTLE, GLASS

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 10019-360-40 identifies a specific commercial package of 6 bottle, glass in 1 package / 100 ml in 1 bottle, glass of Forane, a human prescription drug labeled by Baxter Healthcare Corporation. This inhalant is formulated for respiratory (inhalation) use and contains isoflurane as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Baxter Healthcare Corporation on December 18, 1979. The current certification is valid through December 31, 2027.

How is this Baxter Healthcare Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 10019036040. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
10019-360-40
11-Digit CMS (5-4-2)
10019-0360-40

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.